FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

414427005: Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2529531017 Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2536869011 Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension Is a Product containing chlorphenamine polistirex and hydrocodone polistirex false Inferred relationship Some
    Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension Has manufactured dose form Oral suspension false Inferred relationship Some
    Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Central nervous system agent (substance) false Inferred relationship Some
    Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Chlorphenamine false Inferred relationship Some
    Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydrocodone (substance) false Inferred relationship Some
    Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension Is a Chlorphenamine-containing product in oral dose form false Inferred relationship Some
    Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Chlorphenamine polistirex (substance) false Inferred relationship Some
    Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydrocodone polistirex (substance) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start